2016 Q1 Form 10-Q Financial Statement

#000143774916032049 Filed on May 16, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $1.713M $1.896M
YoY Change -9.65% -7.06%
Cost Of Revenue $1.093M $1.183M
YoY Change -7.61% -7.58%
Gross Profit $620.0K $713.0K
YoY Change -13.04% -6.18%
Gross Profit Margin 36.19% 37.61%
Selling, General & Admin $626.0K $698.0K
YoY Change -10.32% -4.38%
% of Gross Profit 100.97% 97.9%
Research & Development $194.0K $234.0K
YoY Change -17.09% 30.0%
% of Gross Profit 31.29% 32.82%
Depreciation & Amortization $40.00K $58.00K
YoY Change -31.03% -17.14%
% of Gross Profit 6.45% 8.13%
Operating Expenses $820.0K $932.0K
YoY Change -12.02% 2.42%
Operating Profit -$200.0K -$219.0K
YoY Change -8.68% 46.0%
Interest Expense $7.000K $70.00K
YoY Change -90.0%
% of Operating Profit
Other Income/Expense, Net $7.000K $65.00K
YoY Change -89.23%
Pretax Income -$193.0K -$204.0K
YoY Change -5.39% 27.5%
Income Tax
% Of Pretax Income
Net Earnings -$193.0K -$204.0K
YoY Change -5.39% 27.5%
Net Earnings / Revenue -11.27% -10.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.843K -$7.233K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.200M $2.100M
YoY Change -42.86% 23.53%
Cash & Equivalents $1.158M $2.060M
Short-Term Investments
Other Short-Term Assets $200.0K $200.0K
YoY Change 0.0% 0.0%
Inventory $1.428M $1.900M
Prepaid Expenses
Receivables $1.261M $1.000M
Other Receivables $0.00 $100.0K
Total Short-Term Assets $4.095M $5.200M
YoY Change -21.25% 1.96%
LONG-TERM ASSETS
Property, Plant & Equipment $729.0K $600.0K
YoY Change 21.5% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.0K $200.0K
YoY Change -50.0% -50.0%
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $832.0K $848.0K
YoY Change -1.89% -22.91%
TOTAL ASSETS
Total Short-Term Assets $4.095M $5.200M
Total Long-Term Assets $832.0K $848.0K
Total Assets $4.927M $6.048M
YoY Change -18.54% -2.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.013M $900.0K
YoY Change 12.56% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.663M $1.900M
YoY Change -12.47% 46.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.663M $1.900M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.700M $1.900M
YoY Change -10.53% 46.15%
SHAREHOLDERS EQUITY
Retained Earnings -$11.23M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.264M $4.173M
YoY Change
Total Liabilities & Shareholders Equity $4.927M $6.000M
YoY Change -17.88% -3.23%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$193.0K -$204.0K
YoY Change -5.39% 27.5%
Depreciation, Depletion And Amortization $40.00K $58.00K
YoY Change -31.03% -17.14%
Cash From Operating Activities $8.000K $117.0K
YoY Change -93.16% 290.0%
INVESTING ACTIVITIES
Capital Expenditures $72.00K $99.00K
YoY Change -27.27% 147.5%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$72.00K -$99.00K
YoY Change -27.27% 395.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 8.000K 117.0K
Cash From Investing Activities -72.00K -99.00K
Cash From Financing Activities 0.000
Net Change In Cash -64.00K 18.00K
YoY Change -455.56% -160.0%
FREE CASH FLOW
Cash From Operating Activities $8.000K $117.0K
Capital Expenditures $72.00K $99.00K
Free Cash Flow -$64.00K $18.00K
YoY Change -455.56% -280.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dpw Adjustment To Additional Paid In Capital Option To Nonemployees
AdjustmentToAdditionalPaidInCapitalOptionToNonemployees
44000
CY2016Q1 dpw Elimination For Intersegment Revenues
EliminationForIntersegmentRevenues
CY2015Q1 dpw Elimination For Intersegment Revenues
EliminationForIntersegmentRevenues
CY2016Q1 dpw Payments For Options Granted To Employees
PaymentsForOptionsGrantedToEmployees
CY2015Q1 dpw Payments For Options Granted To Employees
PaymentsForOptionsGrantedToEmployees
CY2016Q1 dpw Revenues Excluding Intersegment Revenue
RevenuesExcludingIntersegmentRevenue
1713000
CY2015Q1 dpw Revenues Excluding Intersegment Revenue
RevenuesExcludingIntersegmentRevenue
1896000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1013000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
937000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1261000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1240000
CY2016Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
68000
CY2015Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
77000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-516000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-458000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15009000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14965000
CY2016Q1 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
72000
CY2015Q1 us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
99000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24000
CY2016Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2015Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
50000
CY2016Q1 us-gaap Assets
Assets
4927000
CY2015Q1 us-gaap Assets
Assets
6048000
CY2015Q4 us-gaap Assets
Assets
5099000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
4095000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
4287000
CY2016Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
832000
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
812000
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
90000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
90000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1241000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2110000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1158000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2060000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-83000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-50000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6775971
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6775971
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6775971
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6775971
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-251000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-315000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
1093000
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
1183000
CY2016Q1 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
112000
CY2015Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
211000
CY2016Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13000
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13000
CY2016Q1 us-gaap Depreciation
Depreciation
40000
CY2015Q1 us-gaap Depreciation
Depreciation
34000
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-19000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-68000
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
371000
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y146D
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
371000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438000
CY2016Q1 us-gaap Gross Profit
GrossProfit
620000
CY2015Q1 us-gaap Gross Profit
GrossProfit
713000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-193000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-204000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
76000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-209000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-503000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-27000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
197000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-87000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
261000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-13000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
64000
CY2016Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
887000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1015000
CY2016Q1 us-gaap Inventory Net
InventoryNet
1428000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1542000
CY2016Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
361000
CY2015Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
336000
CY2016Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
180000
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
191000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4927000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5099000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1663000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1628000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
117000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-193000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-204000
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-193000
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-204000
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
820000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
932000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-200000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-219000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-58000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-111000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-58000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-111000
CY2016Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
538000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
480000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65000
CY2016Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
CY2015Q1 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
50000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
72000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
180000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
187000
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
729000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
709000
CY2016Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
234000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11229000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11036000
CY2016Q1 us-gaap Revenues
Revenues
1713000
CY2015Q1 us-gaap Revenues
Revenues
1896000
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y160D
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
255000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
260000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
44000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
47000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
761130
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
598500
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.56
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
40000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1146000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1106000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.52
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.53
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.16
CY2016Q1 us-gaap Share Price
SharePrice
0.41
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y270D
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y262D
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
3471000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
3264000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
4441000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
4173000
CY2016Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2015Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2016Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
500000
CY2015Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
500000
CY2016Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2015Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2015Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6775971
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6775971

Files In Submission

Name View Source Status
0001437749-16-032049-index-headers.html Edgar Link pending
0001437749-16-032049-index.html Edgar Link pending
0001437749-16-032049.txt Edgar Link pending
0001437749-16-032049-xbrl.zip Edgar Link pending
dpw-20160331.xml Edgar Link completed
dpw-20160331.xsd Edgar Link pending
dpw-20160331_cal.xml Edgar Link unprocessable
dpw-20160331_def.xml Edgar Link unprocessable
dpw-20160331_lab.xml Edgar Link unprocessable
dpw-20160331_pre.xml Edgar Link unprocessable
dpw20160401_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
ex99-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending